Daily Digest
Definium's LSD-based pill reduces anxiety in study
Published Thursday, August 13, 2026 · Updated August 13
Narrative Spectrum
- Single-Source Coverage — 1 source
What We Know — Key Points
Key points are extracted by an AI model and may contain errors or omissions. Always check the original sources.- Definium Therapeutics' experimental LSD-based pill, DT120, significantly reduced anxiety symptoms in a late-stage study, with patients on the drug experiencing an 11.6-point drop on a standard anxiety rating scale at week 12, compared with a 6.2-point drop for those on a placebo.
What Is Claimed — Perspectives
Single-Source Coverage
- The Hindu
null
- Read original →· Aug 13
AI-Generated Content
- This topic was generated by an AI system.
- Key points, perspectives, bias labels, and categorisation may contain errors.
- This is not journalism. Do not rely on this content for critical decisions.
- Read our full AI disclaimer for details.